摘要
目的:探讨以单纯眼肌活功能障碍为临床表现的Miller-Fisher综合征(Miller-Fisher syndrome,MFS)
的临床特点及预后。方法:报道2例仅以双侧眼肌功能障碍为主要临床表现的MFS病例,并进行相关文献
复习。结果:例1患者54岁女性,其临床特点表现为感染后视物重影,双侧眼睑痉挛。例2患者67岁男性,
其临床特点表现为无明显诱因视物重影,单侧眼睑下垂,瞳孔扩大,对光反射迟钝,眼球运动障碍。2例患
者均检测到血清抗GQ1b抗体IgG、血清抗GT1a抗体IgG,例2患者还检测到血清抗Sulfatide抗体IgG;患者
均经静脉注射丙种球蛋白治疗,预后良好。回顾既往报道,结合本研究补充2例新病例,得到单纯眼肌症状
的患者资料共7例,其中5例血清抗GQ1b抗体IgG阳性,6例眼外肌麻痹,5例眼内肌麻痹,5例有前驱感染,
7例患者均预后良好。结论:仅有单纯眼部症状的MFS患者极为罕见,本病例分析有助于加深对该类疾病
的了解。
Abstract
To analyze the clinical features and prognosis of Miller-Fisher Syndrome Manifesting
(MFS) with isolated ophthalmoplegia. Methods: We report two cases of MFS presenting with bilateral isolated
ophthalmoplegia as the primary clinical manifestation followed by a systematic review of relevant literature.
Results: Case 1 involved a 54-year-old female presenting with diplopia and bilateral blepharospasm following
infection. Case 2 described a 67-year-old male who developed diplopia without clear triggers, accompanied by
unilateral ptosis, dilated pupils with sluggish light reflex, and ocular motility disorders. Both patients tested
positive for serum anti-GQ1b IgG antibodies and anti-GT1a IgG antibodies; Intravenous immunoglobulin
therapy was administered to both patients, leading to favorable outcomes. By integrating our two new cases with
previously reported instances, we identified a total of seven patients manifesting isolated ocular symptoms: five
were anti-GQ1b IgG positive, six exhibited external ophthalmoplegia, five had internal ophthalmoplegia, five
reported prodromal infections, and all achieved good recovery. Conclusion: Patients with MFS presenting
solely with ocular symptoms are exceedingly rare. These cases significantly enhance our understanding of this
distinctive clinical entity.
关键词
Miller-Fisher综合征;眼睑痉挛;眼肌麻痹;抗GQ1b抗体
Key words
Miller Fisher Syndrome; blepharospasm; ophthalmoplegia; Anti-GQ1b antibody
张宸睿,徐艳,吴双,谢玉,何丹.
以单纯眼肌功能障碍为主要表现的Miller-Fisher综合征2例[J]. 神经损伤与功能重建. 2025, 20(10): 610-613
Two Cases of Miller-Fisher Syndrome Manifesting Primarily as Isolated Ophthalmoplegia[J]. Neural Injury and Functional Reconstruction. 2025, 20(10): 610-613
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
基金
武汉大学中南医院
科技创新平台支撑
项目(低剂量 CD20
单抗治疗视神经脊
髓炎的临床疗效和
安全性研究,No. P
TXM2024016)